Unknown

Dataset Information

CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge.


ABSTRACT: Individuals exposed to beryllium (Be) may develop Be sensitization (BeS) and progress to chronic beryllium disease (CBD). Recent studies with other metal antigens suggest epigenetic mechanisms may be involved in inflammatory disease processes, including granulomatous lung disorders and that a number of metal cations alter gene methylation. The objective of this study was to determine if Be can exert an epigenetic effect on gene expression by altering methylation in the promoter region of specific genes known to be involved in Be antigen-mediated gene expression. To investigate this objective, three macrophage tumor mouse cell lines known to differentially produce tumor necrosis factor (TNF)-α, but not interferon (IFN)-γ, in response to Be antigen were cultured with Be or controls. Followin

SUBMITTER: Tooker BC 

PROVIDER: S-EPMC4907869 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature